Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess
Article
Published on
Journal: Reviews in Endocrine & Metabolic Disorders
[Category] COVID-19, COVID19(2023년), Fulltext, SARS,
Journal: Reviews in Endocrine & Metabolic Disorders
[Category] COVID-19, COVID19(2023년), Fulltext, SARS,
[키워드] cardiometabolic
Case report
Comorbidity
cortisol
Course
COVID-19
cushing’s syndrome
Diseases
Effect
endogenous
Evidence
GC therapy
glucocorticoid
Glucocorticoids
High-dose
highlight
hypercortisolism
immune
Immune-mediated
impairment
incidence
increased risk
Infection
infections
mechanism
mRNA vaccination
outcome
pandemic
Patient
risk factor
SARS-CoV-2
SARS-COV-2 infection
Side effects
Surveillance
the SARS-CoV-2
Topic
triggered
vaccination
Via
[DOI] 10.1007/s11154-021-09670-0 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s11154-021-09670-0 PMC 바로가기 [Article Type] Article